Jazz Pharmaceuticals PLC at Jefferies London Healthcare Conference (Virtual) Transcript
Well, good afternoon, everyone. I apologize, I was about to say good morning because I took a red eye from New York. I have the pleasure of hosting Jazz Pharmaceuticals. For those who don't know me, my name is Akash Tewari. I am a senior biotech analyst at Jefferies.
Joining us today from the Jazz team is Renee Gala, CFO; Dan Swisher, President; and then Samantha Pearce, who is Senior Vice President and Head of Europe and the international business for Jazz. I guess maybe before I get started with my own questions. maybe, Renee, if you want to take a few moments to introduce where Jazz is kind of as a company, and we'll take it from there. Go ahead.
Sure. Great. I'd love to. Well, and also thank you for inviting us. We're thrilled to be here. Before we get started, though, I will remind you, we'll be making forward-looking statements today, so I would point you to our SEC filings on our website for more information on the
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |